Back to Search
CHRISTA BORGMAN, MD
MD
Pediatrics Physician
NPI: 1598179624Individual
Specialties, Licenses & Credentials
Research & Publications (7)
Sunitinib prolongs survival in genetically engineered mouse models of multistep lung carcinogenesis.
PMID 19336729·Cancer Prev Res (Phila)·2009
7-preclinical
HER2YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy.
PMID 19122144·Proc Natl Acad Sci U S A·2009
7-preclinical
Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).
PMID 19079597·PLoS One·2008
7-preclinical
Hsp90 inhibition suppresses mutant EGFR-T790M signaling and overcomes kinase inhibitor resistance.
PMID 18632637·Cancer Res·2008
7-preclinical
Bronchial and peripheral murine lung carcinomas induced by T790M-L858R mutant EGFR respond to HKI-272 and rapamycin combination therapy.
PMID 17613438·Cancer Cell·2007
7-preclinical
The major lung cancer-derived mutants of ERBB2 are oncogenic and are associated with sensitivity to the irreversible EGFR/ERBB2 inhibitor HKI-272.
PMID 17311002·Oncogene·2007
8-other
Activation of a caspase-dependent oxidative damage response mediates TGFbeta1 apoptosis in rat hepatocytes.
PMID 12782012·Exp Mol Pathol·2003
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
Via practice · 2 locations total
- Address
- 55 FRUIT ST
BOSTON, MA 02114 - Phone
- (617) 726-2000
Quick Facts
- NPI
- 1598179624
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 2
- Publications
- 7
Are you this provider?
Claim Your Profile